Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Campieri

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Gut|December 20, 2003
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2009
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with AsacolC Prantera, A Kohn, M Campieri, et al.
Kidney International|September 5, 2001
Reduction of oxaluria after an oral course of lactic acid bacteria at high concentrationC Campieri, M Campieri, V Bertuzzi, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
Gut|October 14, 2004
Modulation of human dendritic cell phenotype and function by probiotic bacteriaA L Hart, K Lammers, P Brigidi, et al.
Inflammatory Bowel Diseases|January 4, 2013
Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBDM Campieri, T Gilat, S Hanauer, et al.
The American Journal of Gastroenterology|September 25, 2001
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatmentS Ulisse, P Gionchetti, S D'Alò, et al.
Inflammatory Bowel Diseases|January 4, 2013
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*M Campieri, H Goebell, S Hanauer, et al.
Neurogastroenterology and Motility|September 25, 2012
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry studyA Agostini, F Benuzzi, N Filippini, et al.
Gut|January 1, 1997
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophilsP Gionchetti, M Vecchi, F Rizzello, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Gut|December 20, 2003
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2009
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with AsacolC Prantera, A Kohn, M Campieri, et al.
Kidney International|September 5, 2001
Reduction of oxaluria after an oral course of lactic acid bacteria at high concentrationC Campieri, M Campieri, V Bertuzzi, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
Gut|October 14, 2004
Modulation of human dendritic cell phenotype and function by probiotic bacteriaA L Hart, K Lammers, P Brigidi, et al.
Inflammatory Bowel Diseases|January 4, 2013
Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBDM Campieri, T Gilat, S Hanauer, et al.
The American Journal of Gastroenterology|September 25, 2001
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatmentS Ulisse, P Gionchetti, S D'Alò, et al.
Inflammatory Bowel Diseases|January 4, 2013
Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*M Campieri, H Goebell, S Hanauer, et al.
Neurogastroenterology and Motility|September 25, 2012
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry studyA Agostini, F Benuzzi, N Filippini, et al.
Gut|January 1, 1997
Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophilsP Gionchetti, M Vecchi, F Rizzello, et al.
Pageof 15